Wockhardt Ltd

Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Wockhardt Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a blend of mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a nuanced outlook for the pharmaceutical and biotechnology company amid evolving market dynamics.

Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Wockhardt Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its daily price, the stock’s mixed signals from key technical indicators such as MACD, RSI, and moving averages suggest a complex market sentiment that investors should carefully analyse.

Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Wockhardt Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, supported by strong weekly and monthly MACD signals and daily moving averages. Despite some bearish cues from monthly RSI and KST indicators, the overall technical landscape suggests a cautiously optimistic outlook for this pharmaceuticals and biotechnology small-cap stock.

Wockhardt Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day decline of 0.51%, the stock’s technical indicators present a complex picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market.

Wockhardt Ltd has recently exhibited a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, signalling renewed investor interest despite a slight dip in daily price. The company’s technical indicators, including MACD, moving averages, and Bollinger Bands, collectively suggest a strengthening upward trajectory, positioning the pharmaceutical small-cap favourably against broader market fluctuations.

Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 July 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Wockhardt Ltd has exhibited a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, supported by mixed signals from key indicators such as MACD, RSI, and moving averages. This nuanced change reflects a cautious optimism in the stock’s near-term trajectory amid broader market volatility.

Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 21 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 10 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 June 2026. The stock demonstrated notable strength with a 1.36% gain during early trading hours, supported by strong institutional interest and sustained buying momentum that has propelled it above key moving averages.

The Sensex declined by 0.62% on 03 Jun 2026, while Wockhardt Ltd surged 7.81%, marking a remarkable 8.35 percentage-point outperformance against its Pharmaceuticals & Biotechnology sector. This sharp intraday advance to Rs 2147, representing a 9.06% high, signals a significant shift in the stock’s short-term momentum.

Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed significant trading activity with a notable surge in value turnover and institutional participation. The stock outperformed its sector and broader market indices, reflecting renewed investor confidence and positive momentum following a recent upgrade in its Mojo Grade.

Wockhardt Ltd experienced a notable decline today, touching an intraday low of Rs 2,005.15, reflecting a 6.82% drop from its previous close. The stock underperformed its sector and broader market indices amid prevailing market pressures and a reversal after a sustained rally.

Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed significant trading activity on 2 June 2026, marked by a substantial value turnover of over ₹33,236 lakhs. Despite this high liquidity and rising investor participation, the stock price declined sharply by 6.16%, underperforming both its sector and the broader Sensex index.

Wockhardt Ltd witnessed a remarkable surge in trading activity on 1 June 2026, emerging as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector. The stock soared to a new 52-week high, buoyed by strong institutional participation and robust order flow, signalling renewed investor confidence in this small-cap pharmaceutical player.